• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Bright Green Corporation (Amendment)

    6/12/23 5:28:12 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BGXX alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A E. Mailloux Enterprises, Inc.: Form SC 13G/A - Filed by newsfilecorp.com

    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    SCHEDULE 13G

    Amendment No. 1

    INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    Bright Green Corporation

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    10920G100

    (CUSIP Number)


    May 31, 2023

    (Date of Event Which Requires Filing of This Statement)

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. 10920G100 13G/A Page 2 of 9 Pages

    1 NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

     
    E. Mailloux Enterprises, Inc.


     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*




    (a) ❏
    (b) ☒
    3 SEC USE ONLY




     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     
    Ontario, Canada


       
      5 SOLE VOTING POWER  
    NUMBER OF 13,700,000 (1)  
    SHARES 6 SHARED VOTING POWER  
    BENEFICIALLY 0  
    OWNED BY 7 SOLE DISPOSITIVE POWER  
    EACH 13,700,000 (1)  
    REPORTING 8 SHARED DISPOSITIVE POWER  
    PERSON WITH 0  
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     
    21,200,000 (1)


     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



    ❏
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     
    11.87% (1)(2)



       
    12 TYPE OF REPORTING PERSON*

     
    CO

         

    (1) Includes 21,200,000 shares of Bright Green Corporation's (the Issuer) common stock, par value $0.0001, of which E. Mailloux Enterprises, Inc. is the beneficial owner. Ernest Mailloux and Cheryl Mailloux are husband and wife and Ernest Mailloux owns and is President of E. Mailloux Enterprises, Inc. Of the 21,200,000 shares of the Issuer's common stock, 13,700,000 shares of common stock are held by E. Mailloux Enterprises, Inc. and 7,500,000 shares of common stock are held by Cheryl Mailloux.  Ernest Mailloux may be deemed to have voting and dispositive power with respect to the shares of common stock held by E. Mailloux Enterprises, Inc. and over the shares of common stock held by Cheryl Mailloux.

    (2) Based upon 178,608,020 shares of common stock of the Issuer outstanding as of June 2, 2023, as disclosed in the Issuer's Form S-3 filed with the U.S. Securities and Exchange Commission on June 5, 2023.


    CUSIP No. 10920G100 13G/A Page 3 of 9 Pages

    1 NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

     
    Ernest Mailloux


     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*




    (a) ❏
    (b) ☒
    3 SEC USE ONLY




     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     
    Canada


       
      5 SOLE VOTING POWER  
    NUMBER OF 13,700,000 (1)  
    SHARES 6 SHARED VOTING POWER  
    BENEFICIALLY 0  
    OWNED BY 7 SOLE DISPOSITIVE POWER  
    EACH 13,700,000 (1)  
    REPORTING 8 SHARED DISPOSITIVE POWER  
    PERSON WITH 0  
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     
    21,200,000 (1)


     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



    ❏
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     
    11.87% (1)(2)



       
    12 TYPE OF REPORTING PERSON*

     
    IN

         

    (1) Includes 21,200,000 shares of Bright Green Corporation's (the Issuer) common stock, par value $0.0001, of which E. Mailloux Enterprises, Inc. is the beneficial owner. Ernest Mailloux and Cheryl Mailloux are husband and wife and Ernest Mailloux owns and is President of E. Mailloux Enterprises, Inc. Of the 21,200,000 shares of the Issuer's common stock, 13,700,000 shares of common stock are held by E. Mailloux Enterprises, Inc. and 7,500,000 shares of common stock are held by Cheryl Mailloux.  Ernest Mailloux may be deemed to have voting and dispositive power with respect to the shares of common stock held by E. Mailloux Enterprises, Inc. and over the shares of common stock held by Cheryl Mailloux.

    (2) Based upon 178,608,020 shares of common stock of the Issuer outstanding as of June 2, 2023, as disclosed in the Issuer's Form S-3 filed with the U.S. Securities and Exchange Commission on June 5, 2023.


    CUSIP No. 10920G100 13G/A Page 4 of 9 Pages

    1 NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

     
    Cheryl Mailloux


     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*




    (a) ❏
    (b) ☒
    3 SEC USE ONLY




     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     
    Canada


       
      5 SOLE VOTING POWER  
    NUMBER OF 7,500,000 (1)  
    SHARES 6 SHARED VOTING POWER  
    BENEFICIALLY 0  
    OWNED BY 7 SOLE DISPOSITIVE POWER  
    EACH 7,500,000 (1)  
    REPORTING 8 SHARED DISPOSITIVE POWER  
    PERSON WITH 0  
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     
    21,200,000 (1)


     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



    ❏
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     
    11.87% (1)(2)



       
    12 TYPE OF REPORTING PERSON*

     
    IN

         

    (1) Includes 21,200,000 shares of Bright Green Corporation's (the Issuer) common stock, par value $0.0001, of which E. Mailloux Enterprises, Inc. is the beneficial owner. Ernest Mailloux and Cheryl Mailloux are husband and wife and Ernest Mailloux owns and is President of E. Mailloux Enterprises, Inc. Of the 21,200,000 shares of the Issuer's common stock, 13,700,000 shares of common stock are held by E. Mailloux Enterprises, Inc. and 7,500,000 shares of common stock are held by Cheryl Mailloux.  Ernest Mailloux may be deemed to have voting and dispositive power with respect to the shares of common stock held by E. Mailloux Enterprises, Inc. and over the shares of common stock held by Cheryl Mailloux.

    (2) Based upon 178,608,020 shares of common stock of the Issuer outstanding as of June 2, 2023, as disclosed in the Issuer's Form S-3 filed with the U.S. Securities and Exchange Commission on June 5, 2023.


    CUSIP No. 10920G100 13G/A Page 5 of 9 Pages

    Item 1 (a).    Name of Issuer:

    Bright Green Corporation

    Item 1 (b). Address of Issuer's Principal Executive Offices:

    401 East Las Olas Blvd.

    Suite 1400

    Ft. Lauderdale, FL 33301

    United States

    Item 2 (a).  Name of Person Filing:

    This Schedule 13G is being filed jointly by E. Mailloux Enterprises, Inc., Ernest Mailloux, and Cheryl Mailloux, who have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

    E. Mailloux Enterprises, Inc., is a corporation formed under the laws of Ontario, Canada with a principal place of business at 3129 Marentette Ave., Unit 2, Windsor, Ontario, Canada N8X 4G1.

    Ernest Mailloux is the President of E. Mailloux Enterprises, Inc., having his principal place of business at 3129 Marentette Ave., Unit 2, Windsor, Ontario, Canada N8X 4G1.

    Cheryl Mailloux is the wife of Ernest Mailloux.

    Ernest Mailloux may be deemed to have voting and dispositive power with respect to the shares of common stock held by E. Mailloux Enterprises, Inc. and over shares of common stock held by Cheryl Mailloux.

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

    3129 Marentette Ave., Unit 2, Windsor, Ontario, Canada N8X 4G1.

    Item 2 (c).  Citizenship:

    E. Mailloux Enterprises, Inc. is an Ontario, Canada corporation.

    Ernest Mailloux is a Canadian citizen.

    Cheryl Mailloux is a Canadian citizen.

    Item 2 (d). Title of Class of Securities:

    Common Stock, par value $0.0001 per share

    Item 2 (e).  CUSIP Number:

    10920G100

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

    (a) ☐ Broker or dealer registered under Section 15 of the Act;

    (b) ☐ Bank as defined in Section 3(a)(6) of the Act;

    (c) ☐ Insurance Company as defined in Section 3(a)(19) of the Act;


    CUSIP No. 10920G100 13G/A Page 6 of 9 Pages

    (d) ☐ Investment Company registered under Section 8 of the Investment Company Act;

    (e) ☐ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) ☐ Employee benefit plan or endowment plan in accordance with Rule 13d- 1(b)(1)(ii)(F);

    (g) ☐ Parent holding company or control person, in accordance with Rule 13d- 1(b)(1)(ii)(G);

    (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

    (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:

    (j) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

     ☒ If this statement is filed pursuant to Rule 13d-1(c), check this box.

    Item 4. Ownership.

    E. Mailloux Enterprises, Inc.

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

    (a) Amount beneficially owned: 21,200,000 (1)

    (b) Percent of class: 11.87% (1)(2)

    (c) Number of shares as to which such person has:

    (i) Sole power to vote or to direct the vote: 13,700,000 (1)

    (ii) Shared power to vote or to direct the vote: 0

    (iii) Sole power to dispose or to direct the disposition of: 13,700,000 (1)

    (iv) Shared power to dispose or to direct the disposition of: 0

    Ernest Mailloux

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

    (a) Amount beneficially owned: 21,200,000 (1)

    (b) Percent of class: 11.87% (1)(2)

    (c) Number of shares as to which such person has:

    (i) Sole power to vote or to direct the vote: 13,700,000 (1)

    (ii) Shared power to vote or to direct the vote: 0

    (iii) Sole power to dispose or to direct the disposition of: 13,700,000 (1)

    (iv) Shared power to dispose or to direct the disposition of: 0


    CUSIP No. 10920G100 13G/A Page 7 of 9 Pages

    Cheryl Mailloux

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

    (a) Amount beneficially owned: 21, 200,000 (1)

    (b) Percent of class: 11.87% (1)(2)

    (c) Number of shares as to which such person has:

    (i) Sole power to vote or to direct the vote: 7,500,000 (1)

    (ii) Shared power to vote or to direct the vote: 0

    (iii) Sole power to dispose or to direct the disposition of: 7,500,000 (1)

    (iv) Shared power to dispose or to direct the disposition of: 0

    (1) Includes 21,200,000 shares of Bright Green Corporation's (the Issuer) common stock, par value $0.0001, of which E. Mailloux Enterprises, Inc. is the beneficial owner. Ernest Mailloux and Cheryl Mailloux are husband and wife and Ernest Mailloux owns and is President of E. Mailloux Enterprises, Inc. Of the 21,200,000 shares of the Issuer's common stock, 13,700,000 shares of common stock are held by E. Mailloux Enterprises, Inc. and 7,500,000 shares of common stock are held by Cheryl Mailloux.  Ernest Mailloux may be deemed to have voting and dispositive power with respect to the shares of common stock held by E. Mailloux Enterprises, Inc. and over the shares of common stock held by Cheryl Mailloux.

    (2) Based upon 178,608,020 shares of common stock of the Issuer outstanding as of June 2, 2023, as disclosed in the Issuer's Form S-3 filed with the U.S. Securities and Exchange Commission on June 5, 2023.

    Item 5. Ownership of Five Percent or Less of a Class.

    If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

    N/A

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

    N/A

    Item 8. Identification and Classification of Members of the Group.

    N/A

    Item 9. Notice of Dissolution of Group.

    N/A

    Item 10.  Certification. By signing below, the undersigned certify that, to the best of the undersigned's knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    CUSIP No. 10920G100 13G/A Page 8 of 9 Pages

    SIGNATURE

    After reasonable inquiry and to the best of the undersigned's knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

    June 12, 2023

      E. MAILLOUX ENTERPRISES, INC.
       
      By: /s/ Ernest Mailloux
        Ernest Mailloux
        President
         
      ERNEST MAILLOUX
       
      By: /s/ Ernest Mailloux
        Ernest Mailloux
         
      CHERYL MAILLOUX
       
      By: /s/ Cheryl Mailloux
        Cheryl Mailloux


    CUSIP No. 10920G100 13G/A Page 9 of 9 Pages

    EXHIBIT INDEX

    Exhibit Description of Exhibit
       
    99.1 Joint Filing Agreement (filed herewith)


    Get the next $BGXX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BGXX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGXX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Bright Green Corporation Announces the next steps for the completion of its restructuring plan

      FORT LAUDERDALE, FLORIDA, March 21, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on March 17, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the "RSA" Restructuring Security Agreement, Disclosure Statement and Plan. The highlights of the Plan and Disclosure will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution. Lynn Stockwell, the new Chief Executive Officer and Chairman of the Board of Directors of Bright Green Corporation, is also the

      3/21/25 9:15:00 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances

      FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the "RSA" Restructuring Security Agreement. The highlights of the RSA will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution. The Company in its restructuring efforts has entered into an agreement with the DEA to immediately withdraw all Cannabis related renewal applications. This agreement will a

      2/24/25 9:15:00 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bright Green Corporation Has Signed Agreement with Majority Shareholder as Plan Sponsor on Prepackaged Plan to Restructure the Company.

      The Company plans to emerge with federal loan guarantees for its 60 new mega farm owner/operators, that collectively will invest $3.5 billion to supply and strengthen the Drugs Made in America supply Chain. FORT LAUDERDALE, FLORIDA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on January 21, 2025, it has entered into a Restructuring Support Agreement (the "RSA") with Lynn Stockwell, a major shareholder of the Company (the "Plan Sponsor") to restructure the Company. To implement the terms of the RSA, the Company will file, and the Plan Sponsor will support the Company's Prepackaged Plan of Reorganization Under Chapte

      1/27/25 8:17:00 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care

    $BGXX
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Bright Green Corporation

      25-NSE - Bright Green Corp (0001886799) (Subject)

      3/21/25 11:19:49 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bright Green Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bright Green Corp (0001886799) (Filer)

      3/21/25 9:15:14 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bright Green Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits

      8-K - Bright Green Corp (0001886799) (Filer)

      2/27/25 4:05:24 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care

    $BGXX
    Leadership Updates

    Live Leadership Updates

    See more
    • (Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

      Singh's appointment comes in support of the Company's next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant based therapies, and expanding into cultivation and manufacturing of other scheduled substances. GRANTS, N.M., Jan. 14, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or "the Company"), announced today their appointment of Groovy Singh, a renowned leader and strategist in the cannabis and wellness industries, as Chief Executive Officer. Singh will replace current CEO Seamus McAuley, who is stepping back from the position to address recently

      1/14/24 10:00:00 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

      Singh's appointment comes in support of the Company's next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant based therapies, and expanding into cultivation and manufacturing of other scheduled substances. GRANTS, N.M., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or "the Company"), announced today their appointment of Groovy Singh, a renowned leader and strategist in the cannabis and wellness industries, as Chief Executive Officer. Singh will replace current CEO Seamus McAuley, who is stepping back from the position to address recently

      10/3/23 11:11:00 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress

      Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval. Commencement of its fundamental capital raise of $500+ million utilizing the U.S. Citizen & Immigration Services EB-5 program, alongside the recently announced full acquisition of Alterola Biotech, showcases the Company's significant progress against its strategic plan. Company has raised short-term working Capital of $5.26m to commence its operations as it looks to capitalize on its historic DEA Registration in Q2 2023 and beyond. GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Brig

      5/24/23 8:00:00 AM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care

    $BGXX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Elmasri Saleem sold $4,951 worth of shares (25,942 units at $0.19), decreasing direct ownership by 2% to 1,103,476 units (SEC Form 4)

      4 - Bright Green Corp (0001886799) (Issuer)

      9/11/24 4:05:11 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Elmasri Saleem sold $14,313 worth of shares (71,809 units at $0.20), decreasing direct ownership by 6% to 1,129,418 units (SEC Form 4)

      4 - Bright Green Corp (0001886799) (Issuer)

      9/10/24 4:05:08 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: Chief Executive Officer Singh Gurvinder was granted 5,500,000 shares (SEC Form 4)

      4/A - Bright Green Corp (0001886799) (Issuer)

      9/9/24 4:05:32 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care

    $BGXX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Bright Green Corporation (Amendment)

      SC 13D/A - Bright Green Corp (0001886799) (Subject)

      9/6/23 5:19:19 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Bright Green Corporation

      SC 13D - Bright Green Corp (0001886799) (Subject)

      6/15/23 4:30:21 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Bright Green Corporation (Amendment)

      SC 13G/A - Bright Green Corp (0001886799) (Subject)

      6/12/23 5:28:12 PM ET
      $BGXX
      Medicinal Chemicals and Botanical Products
      Health Care